Author correction: Bifidobacterium animalis subsp. lactis BLa80 for preventing allergic, respiratory, and gastrointestinal diseases in young children in China: a randomized double-blind placebo-controlled trial

Upon careful re-examination of the published article, we identified two inadvertent errors in the Results section of the Abstract.The original text incorrectly stated the direction of change for antimicrobial peptide levels between the intervention group (IG) and control group (CG).We sincerely apologize for this editorial oversight.This correction does not alter the primary conclusions of the study regarding the efficacy of Bifidobacterium animalis subsp.lactis BLa80 in preventing allergic, respiratory, and gastrointestinal diseases in young children.The two errors should be corrected as follows:1. First correction Original (incorrect): "Postintervention, the IG had significantly lower concentrations of LL-37 ..." Corrected: "Postintervention, the IG had significantly higher concentrations of LL-37..." Second correctionOriginal (incorrect): "Probiotic supplementation was also associated with a lower risk of URTIs (IG vs. CG: 40.3% vs. 20.7%;risk ratio RR, 0.752; 95% confidence interval CI, 0.653-0.866)"Corrected: "Probiotic supplementation was also associated with a lower risk of URTIs (CG vs. IG: 40.3% vs. 20.7%;risk ratio RR, 0.752; 95% confidence interval CI, 0.653-0.866)...